Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the strategic formation of the industry's first ...

Researchers have developed a new artificial intelligence (AI) model that can more accurately predict how proteins interact ...

The process of discovering new drugs and bringing them to market is notoriously slow and inefficient. Amazon Web Services is ...

OpenAI is rolling out an early version of an artificial intelligence model meant to speed up drug discoveries, joining a ...

For every life-changing new drug that comes to market, many candidates fail along the way. An artificial intelligence-based tool developed at the University of Oregon could help scientists better ...

The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.

By Sahil Pandey and Puyaan Singh April 14 (Reuters) - Amazon's cloud unit on Tuesday launched Amazon Bio Discovery, an ...

Artificial intelligence powerhouse OpenAI Group PBC is lending its expertise to Novo Nordisk A/S in a new partnership ...

The MarketWatch News Department was not involved in the creation of this content.-- Free-to-attend event takes place at Pfizer in Cambridge, MA from 16--17 June -- Drug Discovery ...

Amazon has pitched an AI-powered drug discovery platform to the biopharma industry that it says brings together computational ...

The Danish drugmaker will integrate OpenAI's models across research, manufacturing, and commercial operations, with full ...

When chemists design drug candidates, shape matters enormously. Many active pharmaceutical ingredients contain branched ...